Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell™, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B.
View Top Employees from Altimmune, Inc.| Website | http://www.altimmune.com |
| Ticker | NASDAQ:ALT |
| Revenue | $5 million |
| Funding | $71 million |
| Employees | 74 (71 on RocketReach) |
| Founded | 1997 |
| Address | 910 Clopper Rd, Gaithersburg, Maryland 20878, US |
| Phone | (240) 654-1450 |
| Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare, Clinical Trials, Health Care, Test and Measurement, Data and Analytics |
| Web Rank | 4 Million |
| Keywords | Altimmune, Altimmune Inc, Vaxin.Com, Pharmathene, Altimmune Stock |
| Competitors | CaroGen Corporation, Dynavax Technologies, IMV Inc., Immunomic Therapeutics, Inc., Profectus BioSciences, Inc |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325414 Companies, NAICS Code 32 Companies |
Looking for a particular Altimmune, Inc. employee's phone or email?
Altimmune, Inc. Questions
The Altimmune, Inc. annual revenue was $5 million in 2024.
M Scott Harris is the Chief Medical Officer of Altimmune, Inc..
71 people are employed at Altimmune, Inc..
Altimmune, Inc. is based in Gaithersburg, Maryland.
The NAICS codes for Altimmune, Inc. are [3254, 32541, 325, 325414, 32].
The SIC codes for Altimmune, Inc. are [28, 283].
Top Altimmune, Inc. Employees
-
31
-
25+
-
45+
-
41
-
21
-
35+
-
22
-
12
-
11
-
11
Related Companies
